TY  - JOUR
AU  - Mair, Maximilian J
AU  - Lohmann, Philipp
AU  - Galldiks, Norbert
AU  - Belting, Mattias
AU  - Brandal, Petter
AU  - Broen, Martinus P G
AU  - Cicone, Francesco
AU  - Daisne, Jean-François
AU  - Ducray, François
AU  - Ehret, Felix
AU  - Furtner, Julia
AU  - Jakola, Asgeir S
AU  - Niyazi, Maximilian
AU  - Pellerino, Alessia
AU  - Rasschaert, Marika
AU  - Razis, Evangelia
AU  - Sahm, Felix
AU  - Smits, Marion
AU  - Tolboom, Nelleke
AU  - Verger, Antoine
AU  - Le Rhun, Emilie
AU  - Minniti, Giuseppe
AU  - Weller, Michael
AU  - Preusser, Matthias
AU  - Albert, Nathalie L
TI  - Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey.
JO  - European journal of nuclear medicine and molecular imaging
VL  - nn
SN  - 1619-7070
CY  - Heidelberg [u.a.]
PB  - Springer-Verl.
M1  - DKFZ-2025-01148
SP  - nn
PY  - 2025
N1  - epub
AB  - Positron emission tomography (PET) is increasingly used in neuro-oncology. However, little is known about its application across European institutions and reasons for variable implementation.Between June and August 2024, members of the European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) completed a cross-sectional online survey on PET use in neuro-oncological practice.Overall, 103 replies from 20 countries were received. A PET facility was available at 96/103 (93.2
KW  - Brain metastasis (Other)
KW  - Glioma (Other)
KW  - Imaging (Other)
KW  - Meningioma (Other)
KW  - Positron emission tomography (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:40464806
DO  - DOI:10.1007/s00259-025-07366-0
UR  - https://inrepo02.dkfz.de/record/301768
ER  -